Last quarter (Q3 2023), MariMed's total revenue was $38.80M, an increase of 14.41% from the same quarter last year. In Q3, MariMed's net income was $-4.26M. See MariMed’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 145.53M	$ 134.01M	$ 121.46M	$ 50.90M	$ 45.60M	$ 11.85M
Cost of Revenue	$ 41.08M	$ 70.05M	$ -55.20M	$ 19.57M	$ 26.90M	$ 4.04M
Gross Profit	$ 64.41M	$ 63.96M	$ 66.26M	$ 31.32M	$ 18.70M	$ 7.81M
Operating Expense	$ 23.91M	$ 43.59M	$ -39.40M	$ 15.81M	$ 13.03M	$ 11.69M
Operating Income	$ 35.46M	$ 20.37M	$ 26.86M	$ 15.51M	$ 5.67M	$ -3.87M
Net Non Operating Interest Income Expense	$ -7.57M	$ -734.00K	$ -2.25M	$ -9.65M	$ -12.25M	$ -3.77M
Other Income Expense	$ 1.96M	$ 127.00K	$ 797.38K	$ -1.36M	$ -75.23M	$ -5.66M
Pretax Income	$ 5.79M	$ 19.51M	$ 23.82M	$ 4.50M	$ -81.81M	$ -13.31M
Tax Provision	$ 6.91M	$ 5.90M	$ 16.19M	$ 2.07M	$ 67.16K	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -1.12M	$ 13.46M	$ 7.22M	$ 2.14M	$ -81.18M	$ -13.60M
Basic EPS	-	$ 0.04	$ 0.02	$ 0.01	$ -0.39	$ -0.07
Diluted EPS	$ 0.01	$ 0.04	$ 0.02	$ 0.01	$ -0.39	$ -0.07
Basic Average Shares	$ 1.41B	$ 337.70M	$ 326.47M	$ 266.98M	$ 208.72M	$ 192.38M
Diluted Average Shares	$ 1.46B	$ 380.29M	$ 372.40M	$ 324.16M	$ 208.72M	$ 192.38M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 64.98M	$ 113.64M	$ -94.60M	$ 35.38M	$ 39.93M	$ 15.73M
Net Income From Continuing And Discontinued Operation	$ -1.14M	$ 13.47M	$ 7.22M	$ 2.14M	$ -81.18M	$ -13.60M
Normalized Income	$ 43.51M	$ 80.41M	-	$ 3.12M	$ -46.26M	$ -7.99M
Interest Expense	-	-	-	$ 9.81M	$ 12.72M	$ 4.37M
EBIT	$ 13.50M	$ 19.46M	$ 26.07M	$ 14.31M	$ -69.09M	$ -8.94M
EBITDA	$ 23.13M	$ 30.48M	$ 43.84M	$ 16.49M	$ -67.90M	$ -8.28M

Currency in USD

MariMed Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing